Average Co-Inventor Count = 7.12
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Patent Gmbh (22 from 2,943 patents)
2. Vertex Pharmaceuticals, Inc. (2 from 1,151 patents)
3. Paq Therapeutics Inc. (1 from 1 patent)
23 patents:
1. 12415803 - Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)
2. 12404285 - KRAS G12D proteolysis targeting chimeras
3. 12084438 - GCN2 inhibitors and uses thereof
4. 11098041 - Heteroaryl compounds as BTK inhibitors and uses thereof
5. 10793563 - GCN2 inhibitors and uses thereof
6. 10493073 - Heteroaryl compounds as BTK inhibitors and uses thereof
7. 10413562 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
8. 10329270 - Heteroaryl compounds as BTK inhibitors and uses thereof
9. 10253023 - Heteroaryl compounds as BTK inhibitors and uses thereof
10. 10080750 - Aminopyrimidine derivatives for use as modulators of kinase activity
11. 10045985 - Heteroaryl compounds as BTK inhibitors and uses thereof
12. 10016448 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
13. 10005784 - Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
14. 9738648 - Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
15. 9662330 - Aminopyrimidine derivatives for use as modulators of kinase activity